Therapy response and prognosis of patients with early breast cancer with low positivity for hormone receptors- An analysis of 2765 patients from neoadjuvant clinical trials

Erstveröffentlichung

2021

Autoren

Villegas, Sonia L.

Nekljudova, Valentina

Pfarr, Nicole

Engel, Jutta

Untch, Michael

et al.

Wissenschaftlicher Artikel

Erschienen in

European Journal of Cancer ; 148 (2021). - S. 159-170. - ISSN 0959-8049. - eISSN 1879-0852

Link zur Veröffentlichung

https://dx.doi.org/10.1016/j.ejca.2021.02.020

Institutionen

UKU. Klinik für Frauenheilkunde und Geburtshilfe

Schlagwörter

[Freie Schlagwörter]: Breast neoplasms | Breast cancer | Mammary cancer | ER-negative PR-negative HER2-negative breast cancer | Triple-negative breast cancer | Oestrogen receptors | Progesterone receptors | Hormone-dependent neoplasms | Neoadjuvant therapy | Cancer biomarkers | INTERNATIONAL EXPERT CONSENSUS | LIGAND-BINDING ASSAY | PREDICTING RESPONSE | ESTROGEN-RECEPTORS | AMERICAN SOCIETY | ADJUVANT BREAST | ER | CHEMOTHERAPY | IMMUNOHISTOCHEMISTRY | ONCOLOGY/COLLEGE
[DDC Sachgruppe]: DDC 610 / Medicine & health

Metadata

Zur Langanzeige